Furthermore, targeting Hpa2 to the nucleus of breast carcinoma cells prominently decreased their tumorigenic capacities, best exemplified by decreased lung metastasis and prolonged survival of mice implanted with MDA-MB-231-Hpa2-Nuc cells. The gene discussed is NUCB1; the disease is breast carcinoma.